Start Date: 15/03/2018
End Date: 15/03/2018
Venue: The Royal College of Physicians, London, NW1 4LE
The Royal Marsden NHS Foundation Trust
With the rise of clinical genomics and digital imaging in mind, our latest
symposium will provide an update on recent technological developments
and their introduction into the diagnostic arena. The morning session
will showcase applied research taking place in the Centre for Molecular
Pathology (CMP) at our Sutton site, where these new approaches are
driving forward clinical research across the oncological spectrum.
The application of liquid biopsies for novel diagnostics fits the “hot
topics” agenda. In the morning session you will hear from two leading
clinical exponents of circulating tumour DNA (ctDNA) profiling on how
the technique is enabling personalised treatment of cancer patients. The
significant challenges – and opportunities – associated with this field is
bound to trigger much discussion over lunch.
The afternoon is themed by tumour type, with an outstanding faculty,
all associated with the Centre for Molecular Pathology, describing how
the latest clinical trials in their respective areas are being assisted by
combining established methodologies with new technologies, including
gene panel sequencing and digital droplet PCR. We will also hear how
progress on Genomics England’s 100,000 genomes project is beginning
to impact on cancer diagnostics.
More and more doctors are facing the problem of how to handle the
abundant data generated by genomic profiling. We will end the day with
a live demonstration of a Molecular Tumour Board, in which somatic
variants are discussed and placed in clinical context by a panel of
experts and decisions are made on patient care. You are encouraged to
join in the discussion.
The meeting will engage and inform all health professionals and
researchers interested in molecular diagnostics in cancer. The faculty
will be available for lively discussion and debate between sessions.